Abstract
Purpose
Managing patients with advanced bone sarcomas — namely, recurrent, unresectable and metastatic — is mostly aimed at palliation. The role of embolisation for pain relief for these patients has not been previously reported. We therefore performed this study to emphasise the palliative role of embolisation for pain relief of advanced bone sarcoma patients.
Materials and methods
We retrospectively studied 43 patients with advanced bone sarcomas treated with palliative embolisation with N-2-butyl-cyanoacrylate from 2004 to 2011. All patients had primary treatments including chemotherapy, radiation therapy, radiofrequency thermal ablation, and/or surgery for their advanced sarcomas and were referred for embolisation as end-stage treatment for continuous severe local pain. The effect of embolisation was evaluated with a pain score scale and analgesic use. Mean follow-up was 7 (range, 1–19) months); all patients were dead at the last follow-up.
Results
In all patients, angiography showed increased pathological vascularisation of the sarcomas; three to six feeding vessels were embolised in each procedure. Almost complete pain relief and >50% reduction in analgesic use was experienced by 36 patients with highly hypervascular sarcomas and sarcomas in the pelvis and shoulder girdle. Moderate pain relief and 50% reduction in analgesic use was experienced by seven patients with spinal and sacral lesions. Within the available follow-up, no patient had recurrent pain with the same intensity as before embolisation. All patients experienced ischaemic pain at the site of embolisation that resolved completely with analgesics. Six patients with advanced pelvic bone sarcomas experienced paraesthesias at the distribution of the sciatic nerve that resolved completely with methylprednisolone.
Conclusions
Embolisation is a safe and effective local palliative treatment for patients with advanced sarcomas, providing optimum pain relief with the least discomfort and the possibility of minor complications only.
Riassunto
Obiettivo
La gestione dei pazienti con i sarcomi dell’osso in fase avanzata, cioè ricorrenti, non resecabili e metastatici, è volta prevalentemente alla palliazione. Il ruolo dell’embolizzazione nel sollievo dal dolore per questi pazienti non è stato riportato in precedenza. Abbiamo quindi svolto questo studio per enfatizzare il ruolo palliativo dell’embolizzazione nella riduzione del dolore dei pazienti con sarcomi dell’osso in fase avanzata.
Materiali e metodi
Abbiamo studiato retrospettivamente 43 pazienti con sarcomi dell’osso in fase avanzata trattati con embolizzazione palliativa mediante N-2-butil-cianoacrilato dal 2004 al 2011. Tutti i pazienti sono stati sottoposti ad un trattamento di prima linea che includeva chemioterapia, radioterapia, termoablazione con radiofrequenza e/o chirurgia per sarcomi in fase avanzata, e sono stati successivamente trattati con l’embolizzazione come trattamento finale per il dolore locale severo e continuo. Gli effetti dell’embolizzazione sono stati valutati con una scala del dolore e con l’uso di analgesici. Il follow-up medio è stato di 7 mesi (range 1–19 mesi); tutti i pazienti sono deceduti all’ultimo follow-up.
Risultati
In tutti i pazienti l’angiografia mostrava un aumento della vascolarizzazione patologica del sarcoma; da tre a sei vasi afferenti sono stati embolizzati durante ogni procedura. Trentasei pazienti con sarcomi altamente ipervascolarizzati, sarcomi della pelvi e del cingolo scapolare sono andati incontro ad una quasi completa risoluzione del dolore e ad una riduzione dell’uso di analgesici maggiore del 50%. Nel corso del follow-up nessun paziente ha lamentato la ricomparsa del dolore con intensità pari a quella presente prima dell’embolizzazione. Tutti i pazienti hanno manifestato un dolore di tipo ischemico in sede di embolizzazione che si è completamente risolto con l’assunzione di analgesici. Sei pazienti con sarcomi pelvici dell’osso in fase avanzata hanno lamentato la comparsa di parestesie nel territorio di distribuzione del nervo sciatico che si sono completamente risolte con l’assunzione di metilprednilsolone.
Conclusioni
L’embolizzazione è un trattamento palliativo locale sicuro ed efficace per i pazienti con sarcomi ossei in fase avanzata, garantendo un’ottimale risoluzione del dolore, un minimo disagio ed una minor incidenza di complicanze.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References/Bibliografia
Merimsky O, Kollender Y, Inbar M et al (2004) Palliative treatment for advanced or metastatic osteosarcoma. Isr Med Assoc J 6:34–38
Mialou V, Philip T, Kalifa C et al (2005) Metastatic osteosarcoma at diagnosis: prognostic factors and longterm outcome — the French pediatric experience. Cancer 104:1100–1109
Kempf-Bielack B, Bielack SS, Jürgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 23:559–568
Ta HT, Dass CR, Choong PF, Dunstan DE (2009) Osteosarcoma treatment: state of the art. Cancer Metastasis Rev 28:247–263
Errani C, Longhi A, Rossi G et al (2011) Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 11:217–227
Saab R, Rao BN, Rodriguez-Galindo C et al (2005) Osteosarcoma of the pelvis in children and young adults: the St. Jude Children’s Research Hospital experience. Cancer 103:1468–1474
Malawer MM, Link MP, Donaldson SS (1997) Sarcomas of bone. In: DeVita VT, Hellman Sl, Rosenber SA (eds) Cancer: principles and practice of oncology. Lippincott-Raven, Philadelphia, pp 1731–1852
Wittig JC, Bickels J, Priebat D et al (2002) Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 65:1123–1132
Longhi A, Errani C, De Paolis M et al (2006) Primary bone osteosarcoma in the pediatric age: state of the art. Cancer Treat Rev 32:423–436
Bacci G, Briccoli A, Longhi A et al (2005) Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy. Acta Oncol 44:748–755
Grignani G, Palmerini E, Dileo P et al (2011) A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. Ann Oncol 23:508–516
Malawer MM, Buch RG, Thompson WE, Sugarbaker PH (1991) Major amputations done with palliative intent in the treatment of local bony complications associated with advanced cancer. J Surg Oncol 47:121–130
Merimsky O, Kollender Y, Inbar M et al (1997) Palliative major amputation and quality of life in cancer patients. Acta Oncol 36:151–157
Nathan SS, Gorlick R, Bukata S et al (2006) Treatment algorithm for locally recurrent osteosarcoma based on local disease-free interval and the presence of lung metastasis. Cancer 107:1607–1616
Coleman RE (2001) Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165–176
Luger NM, Sabino MAC, Schwei MJ et al (2002) Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs. inflammatory pain. Pain 99:397–406
Ripamonti C, Dickerson ED (2001) Strategies for the treatment of cancer pain in the new millennium. Drugs 61:955–977
Clohisy DR, Mantyh PW (2003) Bone cancer pain. Cancer 97:866–873
Mercadante S, Fulfaro F (2005) World Health Organization guidelines for cancer pain: a reappraisal. Ann Oncol 16:132–135
Hanks GW, Conno F, Cherny N et al (2001) Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 84:587–593
Blum RH, Novetsky D, Shasha D, Fleishman S (2003) The multidisciplinary approach to bone metastases. Oncology (Huntington) 17:845–857
Mercadante S, Portenoy RK (2001) Opioid poorly-responsive cancer pain. part 2: basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manage 21:255–264
King T, Vardanyan A, Majuta L et al (2007) Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer. Pain 132:154–168
Gardell LR, King T, Ossipov MH et al (2006) Opioid receptor-mediated hyperalgesia and antinociceptive tolerance induced by sustained opiate delivery. Neurosci Lett 396:44–49
King T, Ossipov MH, Vanderah TW et al (2005) Is paradoxical pain induced by sustained opioid exposure an underlying mechanism of opioid antinociceptive tolerance? Neurosignals 14:194–205
Ossipov MH, Lai J, King T et al (2004) Antinociceptive and nociceptive actions of opioids. J Neurobiol 61:126–148
Chu LF, Clark DJ, Angst MS (2006) Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study. J Pain 7:43–48
Mercadante S, Ferrera P, Villari P, Arcuri E (2003) Hyperalgesia: an emerging iatrogenic syndrome. J Pain Symptom Manage 26:769–775
Celerier E, Gonzalez JR, Maldonado R et al (2006) Opioid-induced hyperalgesia in a murine model of postoperative pain: role of nitric oxide generated from the inducible nitric oxide synthase. Anesthesiology 104:546–555
Pud D, Cohen D, Lawental E, Eisenberg E (2006) Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects. Drug Alcohol Depend 82:218–223
Vanderah TW, Gardell LR, Burgess SE et al (2000) Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. J Neurosci 20:7074–7079
Mahajan A, Woo SY, Kornguth DG et al (2008) Multimodality treatment of osteosarcoma: radiation in a high-risk cohort. Pediatr Blood Cancer 50:976–982
Hundsdoerfer P, Albrecht M, Rühl U et al (2009) Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma. Eur J Cancer 45:2447–2451
Gutman M, Inbar M, Lev-Shlush D et al (1997) High dose tumor necrosis factor-a and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in >90% response rate and limb preservation. Cancer 79:1129–1137
Bickels J, Manusama ER, Gutman M et al (1999) Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity. Eur J Surg Oncol 25:509–514
Thanos L, Mylona S, Galani P et al (2008) Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol 37:189–194
Callstrom MR, Charboneau JW (2007) Image-guided palliation of painful metastases using percutaneous ablation. Tech Vasc Interv Radiol 10:120–131
Ward E, Munk PL, Rashid F, Torreggiani WC (2008) Musculoskeletal interventional radiology: radiofrequency ablation. Radiol. Clin North Am 46:599–610
Nakamura T, Matsumine A, Yamakado K et al (2009) Lung radiofrequency ablation in patients with pulmonary metastases from musculoskeletal sarcomas Cancer 115:3774–3781
Ding JH, Chua TC, Glenn D, Morris DL (2009) Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases. Interact. Cardiovasc Thorac Surg 9:1051–1053
Rybak LD (2009) Fire and ice: thermal ablation of musculoskeletal tumors. Radiol Clin North Am 47:455–469
Börüban S, Sancak T, Yildiz Y, Saglik Y (2007) EmEmbolization of benign and malignant bone and soft tissue tumors of the extremities. Diagn Interv Radiol 13:164–171
Chuang VP, Benjamin R, Jaffe N et al (1982) Radiographic and angiographic changes in osteosarcoma after intraarterial chemotherapy. AJR Am J Roentgenol 139:1065–1069
Zhang HJ, Yang JJ, Lu JP et al (2009) Use of intra-arterial chemotherapy and embolization before limb salvage surgery for osteosarcoma of the lower extremity. Cardiovasc Intervent Radiol 32:672–678
Hansen ME, Kadir S (1990) Elective and emergency embolotherapy in children and adolescents. Efficacy and safety. Radiologe 30:331–336
Krauel L, Albert A, Mora J et al (2009) Use of angioembolization as an effective technique for the management of pediatric solid tumors. J Pediatr Surg 44:1848–1855
Rossi G, Mavrogenis AF, Rimondi E et al (2011) Selective arterial embolisation for bone tumours: experience of 454 cases. Radiol Med 116:793–808
Mavrogenis AF, Rossi G, Rimondi E et al (2011) Embolisation for vascular injuries complicating elective orthopaedic surgery. Eur J Vasc Endovasc Surg 42:676–683
Chuang VP (1984) Angiographic contributions to the management of advanced cancer. AJR Am J Roentgenol 142:385–388
Cullen JW, Jamroz BA, Stevens SL et al (2005) The value of serial arteriography in osteosarcoma: delivery of chemotherapy, determination of therapy duration, and prediction of necrosis. CardioVasc Interv Radiol 16:1107–1119
Chu JP, Chen W, Li JP et al (2007) Clinicopathologic features and results of transcatheter arterial chemoembolization for osteosarcoma. Cardiovasc Intervent Radiol 30:201–206
Owen RJ (2008) Embolization of musculoskeletal tumors. Radiol Clin North Am 46:535–543
Gottfried ON, Schloesser PE, Schmidt MH, Stevens EA (2004) Embolization of metastatic spinal tumors. Neurosurg Clin N Am 15:391–399
Mavrogenis AF, Rossi G, Rimondi E et al (2011) Embolization of bone tumors. Orthopedics 34:303–310
Breslau J, Eskridge JM (1995) Preoperative embolization of spinal tumors. J Vasc Interv Radiol 6:871–875
Vlahos L, Benakis V, Dimakakos P et al (1980) Acomparative study of thedegree of arterial recanalization in kidneys of dogs following transcatheter embolization with eight different materials. Eur Urol 6:180–185
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mavrogenis, A.F., Rossi, G., Altimari, G. et al. Palliative embolisation for advanced bone sarcomas. Radiol med 118, 1344–1359 (2013). https://doi.org/10.1007/s11547-012-0868-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-012-0868-3